Research Topics
| ROBERT W WINSLOWSummaryAffiliation: University of California Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Blood substitutesRobert M Winslow
Sangart, Inc, San Diego, California 92121, USA
Curr Opin Hematol 9:146-51. 2002..Comparison of oxygen carriers with more traditional starch-based products provides new insight into the interaction of oxygen transport, microvascular perfusion, and blood volume expansion...
Red cell substitutesRobert M Winslow
Sangart, Inc, and Department of Bioengineering, University of California, San Diego, CA 92121, USA
Semin Hematol 44:51-9. 2007..After more than a century of research, one of these new solutions should find use as an alternative to red cells for transfusion in certain clinical settings...
MP4, a new nonvasoactive polyethylene glycol-hemoglobin conjugateRobert M Winslow
Sangart, Inc, San Diego, CA 92121, USA
Artif Organs 28:800-6. 2004..Preservation of functional capillary density and prevention of vasoconstriction further contribute to the effectiveness of this new formulation. MP4 is currently being tested in humans...
Comparison of PEG-modified albumin and hemoglobin in extreme hemodilution in the ratRobert M Winslow
Sangart, 11189 Sorrento Valley Rd, Suite 104, San Diego, CA 92121, USA
J Appl Physiol 97:1527-34. 2004..We conclude that, despite its low PO2 necessary to obtain 50% O2, MP4 effectively substitutes for red blood cell hemoglobin in its ability to oxygenate tissues in extreme hemodilution...
Current status of oxygen carriers ('blood substitutes'): 2006R M Winslow
Sangart, Inc, San Diego, USA
Vox Sang 91:102-10. 2006..Such products may seem counterintuitive by traditional standards, but it is hoped that they will be less toxic, more beneficial to patients, and more economical to produce...
Alternative oxygen therapeutics: products, status of clinical trials, and future prospectsRobert M Winslow
Sangart, Inc, 11189 Sorrento Valley Road, Suite 104, San Diego, CA 92121, USA
Curr Hematol Rep 2:503-10. 2003..It is possible that one or more of the earlier products may be approved by regulatory agencies in 1 or 2 years. However, a universally compatible and safe product most likely will be unavailable for several more years...
The role of hemoglobin oxygen affinity in oxygen transport at high altitudeRobert M Winslow
Sangart Inc, San Diego, CA 92121, United States
Respir Physiol Neurobiol 158:121-7. 2007....
Red cell age and loss of function: advance or SNO-job?Robert M Winslow
Department of Bioengineering, University of California, San Diego, CA, USA
Transfusion 48:411-4. 2008
Current status of blood substitute research: towards a new paradigmR M Winslow
Sangart, Inc, San Diego, CA 92121, USA
J Intern Med 253:508-17. 2003..These include increased O2 affinity (low P50) and increased viscosity and oncotic pressure. These second-generation solutions hold greater promise for clinical development...
Cell-free oxygen carriers: scientific foundations, clinical development, and new directionsRobert M Winslow
Sangart Inc, San Diego, California, USA
Biochim Biophys Acta 1784:1382-6. 2008..Because of its low P50 and increased molecular size, the release of O2 in resistance vessels (arterioles) by Hemospan is restricted, and vasoconstriction is greatly reduced...
Targeted O2 delivery by low-p50 hemoglobin: a new basis for hemoglobin-based oxygen carriersRobert M Winslow
Sangart, Inc, San Diego, CA 92121, USA
Artif Cells Blood Substit Immobil Biotechnol 33:1-12. 2005..Preservation of functional capillary density and prevention of vasoconstriction further contribute to the effectiveness of this new formulation...
MalPEG-hemoglobin (MP4) improves hemodynamics, acid-base status, and survival after uncontrolled hemorrhage in anesthetized swineMark A Young
Sangart, San Diego, CA, USA
Crit Care Med 33:1794-804. 2005..CONCLUSION: These data demonstrate that restoration of oxygen delivery with a small volume of MP4 yields significant recovery from hemorrhage without systemic vasoconstriction...
Effects of extreme hemodilution with hemoglobin-based O2 carriers on microvascular pressurePedro Cabrales
Department of Bioengineering, University of California San Diego, La Jolla, CA 92093 0412, USA
Am J Physiol Heart Circ Physiol 288:H2146-53. 2005..Microvascular resistance in arterioles with a diameter range of 70-80 microm showed an increase relative to control with alpha alpha Hb, whereas MP4 caused a decrease...
A quantitative framework for the design of acellular hemoglobins as blood substitutes: implications of dynamic flow conditionsRussell H Cole
Department of Mechanical Engineering, 140 Hesse Hall, University of California, Berkeley, CA 94720, USA
Biophys Chem 128:63-74. 2007..The model predicts that regardless of size, hemoglobin solutions with higher p50 will present excess O(2) to arteriolar walls. Oversupply of O(2) to arteriolar walls may cause constriction and paradoxically reduced capillary perfusion...
Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriersAmy G Tsai
Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093 0412, USA
Blood 108:3603-10. 2006....
MP4, a new nonvasoactive PEG-Hb conjugateKim D Vandegriff
Sangart, Inc, 11189 Sorrento Valley Road, Suite 104, San Diego, CA 92121, USA
Transfusion 43:509-16. 2003..No significant elevation in mean arterial pressure was observed. CONCLUSION: MP4 appears to be free of a pressor effect, a major limitation to the development of a safe and effective RBC substitutes in the past...
Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeuticsAmy G Tsai
Department of Bioeengineering, University of California, San Diego, La Jolla 92023, USA
Am J Physiol Heart Circ Physiol 285:H1411-9. 2003..Higher O2 extraction of both red blood cell and plasma hemoglobin in capillaries represents a new mechanism of action of cell-free hemoglobin. High O2 affinity appears to be an important property for cell-free hemoglobin solutions...
Toxicity and hemodynamic effects after single dose administration of MalPEG-hemoglobin (MP4) in rhesus monkeysMark A Young
Sangart, Inc, San Diego, CA 92121, USA
Transl Res 149:333-42. 2007..These results demonstrate that MP4 is safe and is without hemodynamic effects when administered as an exchange transfusion of 30% of estimated blood volume...
Effect of maleimide-polyethylene glycol hemoglobin (MP4) on hemodynamics and acid-base status after uncontrolled hemorrhage in anesthetized swine: comparison with crystalloid and bloodMark A Young
Sangart, Inc San Diego, CA, USA
J Trauma 63:1234-44. 2007..This study evaluated resuscitation with MP4 after uncontrolled hemorrhage in anesthetized swine, and compared the effects of MP4 alone with those of standard-of-care crystalloid or crystalloid + blood...
Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamstersReto Wettstein
Department of Bioengineering, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093 0412, USA
Crit Care Med 31:1824-30. 2003..5 cP, colloid osmotic pressure of 49 mm Hg, and p50 of 5.5 mm Hg, improves systemic and microvascular variables after hemorrhage compared with shed blood (SB) and 5% hydroxyethyl starch (HES)...
Sites of modification of hemospan, a poly(ethylene glycol)-modified human hemoglobin for use as an oxygen therapeuticKim D Vandegriff
Sangart Inc, San Diego, California 92121, USA
Bioconjug Chem 19:2163-70. 2008....
Hemospan improves outcome in a model of perioperative hemodilution and blood loss in the rat: comparison with hydroxyethyl starchMark A Young
Sangart Inc, San Diego, CA 92121, USA
J Cardiothorac Vasc Anesth 23:339-47. 2009..MP4 was compared with hydroxyethyl starch solutions of differing concentrations (ie, HES 260/0.45 and HES 130/0.4)...
Hemospan: design principles for a new class of oxygen therapeuticKim D Vandegriff
Sangart, Inc, San Diego, CA, USA
Artif Organs 33:133-8. 2009..Phase III trials in orthopedic surgery have recently completed enrollment in Europe...
Resuscitation from hemorrhagic shock with MalPEG-albumin: comparison with MalPEG-hemoglobinReto Wettstein
Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093 0412 USA
Shock 22:351-7. 2004..7 cP (vs. 2.5 cP for MalPEG-Hb). The present results show that both solutions are efficacious plasma expanders and that the hemoglobin-based solution provides improved oxygen distribution and tissue Po2 in the hamster chamber model...
Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation ratesKim D Vandegriff
Sangart, Inc, 6175 Lusk Blvd, San Diego, California 92121 USA
Biochem J 399:463-71. 2006....
Kinetics of NO and O2 binding to a maleimide poly(ethylene glycol)-conjugated human haemoglobinKim D Vandegriff
Sangart Inc, 11189 Sorrento Valley Rd, Ste. 104, San Diego, CA 92121, USA
Biochem J 382:183-9. 2004..Alternatively, the unique O2-binding characteristics with low p50 and co-operativity suggest that the 'R-state' conformation of MalPEG-Hb is in a more T-state configuration and restricted from conformational change...
Microvascular oxygen distribution in awake hamster window chamber model during hyperoxiaAmy G Tsai
Department of Bioengineering, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093 0412, USA
Am J Physiol Heart Circ Physiol 285:H1537-45. 2003....
A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycolMagnus Bjorkholm
Karolinska Hospital and Institute, Stockholm, Sweden
Haematologica 90:505-15. 2005..A phase I clinical trial of MP4 was undertaken to evaluate whether MP4 elicits the clinical side effects associated with previous hemoglobin-based solutions...
Extreme hemodilution with PEG-hemoglobin vs. PEG-albuminPedro Cabrales
La Jolla Bioengineering Institute, 505 Coast Blvd S, Suite 405, La Jolla, CA 92037, USA
Am J Physiol Heart Circ Physiol 289:H2392-400. 2005..MP4 was significantly higher than MPA (P < 0.05) and was not statistically different from baseline, an effect due to the additional oxygen release to the tissue by the Hb MP4...
Solution structure of poly(ethylene) glycol-conjugated hemoglobin revealed by small-angle X-ray scattering: implications for a new oxygen therapeuticDmitri I Svergun
European Molecular Biology Laboratory, Hamburg Outstation, Hamburg, Germany
Biophys J 94:173-81. 2008..The proposed methodology for assessment of low-resolution structures and interactions is a powerful means for rational design of PEGylated therapeutic agents...
Enhanced molecular volume of conservatively pegylated Hb: (SP-PEG5K)6-HbA is non-hypertensiveSeetharama A Acharya
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA
Artif Cells Blood Substit Immobil Biotechnol 33:239-55. 2005..The results demonstrate that a non-hypertensive PEG-Hb can be generated by conjugation of a lower number of PEG chains than previously reported...
Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4)Dan Drobin
Department of Anesthesiology, , S-118 83 Stockholm, Sweden
J Appl Physiol 96:1843-53. 2004....
A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified Hemoglobin (Hemospan) in patients undergoing major orthopedic surgeryChristina Olofsson
Karolinska University Hospital, Solna, Stockholm, Sweden
Anesthesiology 105:1153-63. 2006..The absence of a high frequency of serious adverse events suggests that further clinical trials should be undertaken...
To publish or not to publishRobert M Winslow
J Lab Clin Med 145:221; discussion 222. 2005
Hemoglobin-based blood substitutes and risk of myocardial infarction and deathPeter E Keipert
JAMA 300:1295-6; author reply 1298-9. 2008
Research Grants
- Oxygen Carriers for Hypovolemic Circulatory CollapseRobert Winslow; Fiscal Year: 2007..The research described in this proposal will focus on molecules and formulations specifically tailored for use in prehospital and trauma settings. ..
